PR 13-1A Statement of cash flows-indirect method The comparative balance sheet of Livers Inc. for December 31, 2013 and 2012, is shown as follows: Dec. 31, 2013 Dec. 31, 2012 Assets Cash Accounts receivable (net) Inventories $ 155,000 450,000 $ 150,000 400,000 770,000 750,000 Investments 100,000 Land..... 500,000 Equipment.. 1,400,000 1,200,000 Accumulated depreciation-equipment Total assets (600,000) $2,675,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $ 340,000 (500,000) $2,100,000 $ 300,000 Accrued expenses payable (operating expenses) 45,000 50,000 Dividends payable.. 30,000 25,000 Common stock, $4 par 700,000 600,000 Paid-in capital: Excess of issue price over par-common stock 200,000 175,000 1,360,000 950,000 Retained earnings. Total liabilities and stockholders' equity. $2,675,000 $2,100,000 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: A. The investments were sold for $175,000 cash. B. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. D. The common stock was issued for cash.